Sreenath M. Krishnan
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 18, 2023
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study.
Journal: Clinical pharmacology and therapeutics
Published: August 23, 2022
Bayesian forecasting of tumor size metrics and overall survival.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 23, 2022
Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxel.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 09, 2021
Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 13, 2020
Regulation of Thiamine (Vitamin B1)-Dependent Metabolism in Mammals by p53.
Journal: Biochemistry. Biokhimiia
Published: October 12, 2020
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 06, 2020
Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 17, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026